期刊文献+

INVESTIGATION OF THE RELATIONSHIP BETWEEN CELL PROLIFERATIVE ACTIVITY AND INVASION, METASTASIS AND PROGNOSIS OF GASTRIC CANCER

INVESTIGATION OF THE RELATIONSHIP BETWEEN CELL PROLIFERATIVE ACTIVITY AND INVASION, METASTASIS AND PROGNOSIS OF GASTRIC CANCER
下载PDF
导出
摘要 To evaluated Bromodeoxyuridine (BrdUrd) /DNA doubleparametric method in detection of gastric carcinoma and to analyze the relationships of cellular BrdUrd labeling indices(LI), G2/M-phase fraction(G2/MPE) and DNA content to the depth of invasion, lymphatic vessel invasion, lymphatic node metastasis, peritoneal dissemination and blood vessel invasion and prognosis. Methods: Fresh tumor samples from 60 cases were examined by BrdUrd/DNA doubleparametric flowcytometry. Propidium iodide(PI) was used as fluorescent probe for total cellular DNA and a monoclonal antibody against BrdUrd incorporated into DNA. Fluorescein-labeled goat anti-mouse antibody was used as second antibody. Results: The values of BrdUrd LI in patients with serosa invasion was significantly higher than those without serosa invasion (P<0.01); there was statistical significance in 5-year survival rate between the two groups (P<0.01). Both BrdUrd LI and G2/MPF values were significantly higher in patients with lymphatic vessel invasion than those without invasion (P<0.01); the patients with lymphatic vascular invasion carried a significantly poor prognosis (P<0.01). Both BrdUrd LI and G2/MPF values were significantly higher in patients with lymphatic node metastasis than those without metastasis (P<0.01), there was a statistical significance in 5 years survival between these 2 groups. The incidence of lymphatic node metastasis was significantly higher in aneuploid carcinoma (P<0.05), and the patients with aneuploid carried a significantly poor prognosis (P<0.05). Patients with peritoneal dissemination had a significantly worse prognosis (P<0.01). G2/MPF values were significantly higher in patients with blood vessel invasion than those without invasion (P<0.01). Conclusion: Cellular BrdUrd LI, G2/MPF and DNA content are related to depth of invasion, lymphatic vessel invasion, peritoneal dissemination, blood vessel invasion and prognosis of gastric carcinoma. To evaluated Bromodeoxyuridine (BrdUrd) /DNA doubleparametric method in detection of gastric carcinoma and to analyze the relationships of cellular BrdUrd labeling indices(LI), G2/M-phase fraction(G2/MPE) and DNA content to the depth of invasion, lymphatic vessel invasion, lymphatic node metastasis, peritoneal dissemination and blood vessel invasion and prognosis. Methods: Fresh tumor samples from 60 cases were examined by BrdUrd/DNA doubleparametric flowcytometry. Propidium iodide(PI) was used as fluorescent probe for total cellular DNA and a monoclonal antibody against BrdUrd incorporated into DNA. Fluorescein-labeled goat anti-mouse antibody was used as second antibody. Results: The values of BrdUrd LI in patients with serosa invasion was significantly higher than those without serosa invasion (P<0.01); there was statistical significance in 5-year survival rate between the two groups (P<0.01). Both BrdUrd LI and G2/MPF values were significantly higher in patients with lymphatic vessel invasion than those without invasion (P<0.01); the patients with lymphatic vascular invasion carried a significantly poor prognosis (P<0.01). Both BrdUrd LI and G2/MPF values were significantly higher in patients with lymphatic node metastasis than those without metastasis (P<0.01), there was a statistical significance in 5 years survival between these 2 groups. The incidence of lymphatic node metastasis was significantly higher in aneuploid carcinoma (P<0.05), and the patients with aneuploid carried a significantly poor prognosis (P<0.05). Patients with peritoneal dissemination had a significantly worse prognosis (P<0.01). G2/MPF values were significantly higher in patients with blood vessel invasion than those without invasion (P<0.01). Conclusion: Cellular BrdUrd LI, G2/MPF and DNA content are related to depth of invasion, lymphatic vessel invasion, peritoneal dissemination, blood vessel invasion and prognosis of gastric carcinoma.
机构地区 Department of Oncology
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2004年第2期113-117,共5页 中国癌症研究(英文版)
基金 This work was supported by The Doctor Starting Foundation of Liaoning Province (No. 971012).
关键词 Stomach neoplasmas Proliferative activity Metastasis and invasion Flow cytometry PROGNOSIS Stomach neoplasmas Proliferative activity Metastasis and invasion Flow cytometry Prognosis
  • 相关文献

参考文献20

  • 1[1]Kim JY, Cho HJ. DNA ploidy patterns in gastric adenocarcinoma[J]. J Korean Med Sci 2000; 15: 15-166.
  • 2[2]Abad M, Ciudad J, Rincon M, et al. DNA aneuploidy by flow cytometry is an independent prognostic factor in gastric cancer[J]. Anal Cell Pathol 1998; 16: 223-31.
  • 3[3]Chistyyakova O, Zubrikhina G. Flow cytometric analysis of DNA content in gastric and colorectal cancer[J]. Anal Quant Cytol Histol 1998; 20: 52-8.
  • 4[4]Baba H, Korenaga D, Kakeji Y, et al. DNA ploidy and clinical implications in gastric cancer[J]. Surgery 2002; 131: S63-70.
  • 5[5]Santoro E, Carboni M, Catarci M, et al. DNA ploidy, proliferative index and EGF-R status in 130 cases of resected gastric cancer-a multivariate analysis[J]. Hepatogastroenterology 1997; 44: 826-37.
  • 6[6]Ranaldi R, Santinelli A, Fabris G, et al. A flow cytometric study of early gastric cancer The detection of high proliferative activity adds important information to the prognosis[J]. Pathol Res Pract 1996; 192: 1202-5.
  • 7[7]Yokota T, Kunii Y, Saito T, et al. Prognostic factors of gastric cancer tumors of less than 2 cm in diameter: rationale for limited surgery[J]. Eur J Surg Oncol 2002; 28: 209-13.
  • 8[8]Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer in Japan and its limits of radicality[J]. World J Surg 1987; 11: 418-25.
  • 9[9]Adachi Y, Yasuda K, Inomata M, et al. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type[J]. Cancer 2000; 89: 1418-24.
  • 10[10]Lee J, Noh S, Lee K, et al. DNA ploidy patterns in advanced gastric carcinoma; is it a clinically applically applicable prognosticator[J]. Hepatogastro- enterology 2001; 48:1793-6.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部